2020 | A National Consensus Survey for Current Practice in Brain Tumor Management I: Antiepileptic Drug and Steroid Usage
| Brain Tumor Research and Treatment |
2020 | A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma
| Brain Tumor Research and Treatment |
2020 | A National Consensus Survey for Current Practice in Brain Tumor Management III: Brain Metastasis and Primary Central Nervous System Lymphoma
| Brain Tumor Research and Treatment |
2022 | An interpretable radiomics model to select patients for radiotherapy after surgery for WHO grade 2 meningiomas
| RADIATION ONCOLOGY |
2019 | Analysis of patterns of failure and appraisal of postoperative radiation field for grade II-III meningioma | Journal of Neuro-Oncology |
2020 | ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data
| RADIATION ONCOLOGY |
2018 | Cardiac Metastasis from Clivus Chordoma | WORLD NEUROSURGERY |
2018 | Clinical outcomes of radiotherapy for spinal cord ependymoma with adverse prognostic features: a single-center study. | JOURNAL OF NEURO-ONCOLOGY |
2019 | Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era
| RADIATION ONCOLOGY |
2017 | Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea
| CANCER RESEARCH AND TREATMENT |
2013 | Development of a porcine skin injury model and characterization of the dose-dependent response to high-dose radiation
| JOURNAL OF RADIATION RESEARCH |
2014 | Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response. | ANNALS OF HEMATOLOGY |
2020 | Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma
| SCIENTIFIC REPORTS |
2014 | Feasibility and Outcomes of Hypofractionated Simultaneous Integrated Boost-Intensity Modulated Radiotherapy for Malignant Gliomas: A Preliminary Report
| YONSEI MEDICAL JOURNAL |
2019 | Impact of H3.3 K27M Mutation on Prognosis and Survival of Grade IV Spinal Cord Glioma on the Basis of New 2016 World Health Organization Classification of the Central Nervous System | NEUROSURGERY |
2017 | Impact of Including Peritumoral Edema in Radiotherapy Target Volume on Patterns of Failure in Glioblastoma following Temozolomide-based Chemoradiotherapy
| SCIENTIFIC REPORTS |
2017 | Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis.
| MEDICINE |
2012 | MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study. | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2018 | Multiple systemic extraneural metastasis of glioblastoma | CHIRURGIA |
2017 | Novel recursive partitioning analysis classification for newly diagnosed glioblastoma: A multi-institutional study highlighting the MGMT promoter methylation and IDH1 gene mutation status | RADIOTHERAPY AND ONCOLOGY |
2015 | Patterns of Failure Following Multimodal Treatment for Medulloblastoma: Long-Term Follow-up Results at a Single Institution
| CANCER RESEARCH AND TREATMENT |
2019 | Patterns of local recurrence after curative resection and reconstruction for oropharyngeal and oral cancers: Implications for postoperative radiotherapy target volumes | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
2022 | Patterns of recurrence according to the extent of resection in patients with IDH-wild-type glioblastoma: a retrospective study | JOURNAL OF NEUROSURGERY |
2017 | Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma
| ONCOTARGET |
2016 | Pseudoprogression in glioblastoma patients: the impact of extent of resection | JOURNAL OF NEURO-ONCOLOGY |
2018 | Recurrence patterns after maximal surgical resection and postoperative radiotherapy in anaplastic gliomas according to the new 2016 WHO classification
| SCIENTIFIC REPORTS |
2019 | Solitary fibrous tumor/hemangiopericytoma: treatment results based on the 2016 WHO classification | JOURNAL OF NEUROSURGERY |
2020 | Survival benefit of lobectomy over gross-total resection without lobectomy in cases of primary glioblastoma in non-eloquent area: a retrospective study | JOURNAL OF NEUROSURGERY |
2020 | Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas
| CANCER RESEARCH AND TREATMENT |
2021 | The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1
| Brain Tumor Research and Treatment |
2021 | The Korean Society for Neuro-Oncology (KSNO) guideline for antiepileptic drug usage of brain tumor: Version 2021.1
| Brain Tumor Research and Treatment |
2019 | The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01
| Brain Tumor Research and Treatment |
2019 | The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01
| Brain Tumor Research and Treatment |
2019 | The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01
| Brain Tumor Research and Treatment |
2017 | The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma | ANNALS OF HEMATOLOGY |
2016 | The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma | BRITISH JOURNAL OF HAEMATOLOGY |
2016 | Treatment Outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal Tumors.
| PLOS ONE |
2019 | Treatment outcomes of radiotherapy for primary spinal cord glioma | STRAHLENTHERAPIE UND ONKOLOGIE |
2020 | Validation and optimization of a web-based nomogram for predicting survival of patients with newly diagnosed glioblastoma | STRAHLENTHERAPIE UND ONKOLOGIE |
2018 | Validation of a novel molecular RPA classification in glioblastoma (GBM-molRPA) treated with chemoradiation: A multi-institutional collaborative study | RADIOTHERAPY AND ONCOLOGY |